Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Healthy gut study sets baseline for nerve disease research

NCT ID NCT03054415

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at the gut's own nervous system in 16 healthy adults to understand how it normally works. Researchers took small tissue samples from the colon during an endoscopy and measured how the rectum responds to pressure. The goal is to use this information as a healthy reference for future studies on patients with conditions like spina bifida.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

16 people

The number who actually took part.

Started

May 2017

Finished

Sep 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * subject aged between 18 and 65 years old age and sex matched with the first sixteen patients included and evaluated in the ANOSPIN study * subject who gave their written consent to participate to the present study * subject not included in another study * subject covered by social insurance system Exclusion Criteria: * Pregnant or nursing women; * Anticoagulants therapy or coagulation disorders; * Past history of anal or rectal surgery * Crohn disease or ulcerative colitis * Irritable bowel syndrome according to the Rome III criteria; * Past history of pelvic radiotherapy * Pas history of rectal or anal cancer * Anorectal symptoms : faecal incontinence, constipation, anorectal pain, rectal prolapse; * CCIS \>5 (faecal incontinence); * Kess Score \>9 (constipation); * Colonic irrigation; * Use of laxatives; * Abnormal colonic mucosa * Period of exclusion; * Patient under guardianship or unable to give their consent;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rennes University Hospital

    Rennes, 35033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.